Abstract
In this research project, we aim to apply the innovative and promising strategy of fragment-based drug discovery (FBDD), an approach that employs small molecules, known as fragments, to identify and optimize interactions with therapeutic targets. The primary focus will be on the fragment 5,8-dihydro-1,6-naphthyridin-7(6H)-one, aligned with the advancements of the team at Durham University…